The epidemic situation, the mass character of the lesion, make it necessary to differentiate hemorrhagic conjunctivitis from another very widespread and well-studied disease - acute epidemic adenoviral conjunctivitis.
In the treatment of leprosy damage to the organ of vision, the main thing is to conduct general specific therapy. The total duration of treatment of patients with lepromatous and borderline type of leprosy is 5-10 years, with tuberculoid and undifferentiated - at least 3-5 years.
Prior to the widespread use of sulfonamides, damage to the organ of vision in leprosy occurred in a large percentage of cases: 77.4% in each case. No other infectious disease had such a high incidence of eye damage.
The causative agent of human leprosy - Mycobacterium leprae (M. Leprae hominis, M. Hanseni), described in 1874 by G. Hansen, belongs to the genus Mycobacterium.
Leprosy (obsolete name - leprosy) is one of the most severe chronic infectious diseases of a person, manifested by damage to the skin, mucous membranes, peripheral nervous system, organ of vision, lymph nodes and internal organs.
Diphtheria is an acute infectious disease characterized by fibrinous inflammation in the area of the entrance gate of the infection. Hence the name of the disease (Greek diphtera - film).
The introduction, with perforated wounds, perforated corneal ulcers or hematogenous fungal pathways into the cavity of the eyeball, is fraught with severe intraocular inflammations, often resulting in death of the eye.
Increased in recent years, fungal diseases of the cornea, often proceeding hard and with a bad outcome, are of leading importance in the fungal pathology caused by the organ of vision.
